Reuters logo
BRIEF-WntResearch: positive results from clinical study with drug candidate Foxy-5
March 21, 2017 / 12:48 PM / in 8 months

BRIEF-WntResearch: positive results from clinical study with drug candidate Foxy-5

March 21 (Reuters) - WntResearch AB:

* Says has obtained positive results from the analyses of patient tumour tissue samples before and after treatment in a Phase 1b study with Foxy-5 – a drug candidate intended to inhibit tumours from spreading in cancer patients

* Based on the obtained results, the company has defined the dose level for the upcoming Phase 2 study, which was one of the objectives with this clinical study

Source text: bit.ly/2nZMFbs

Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below